UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 29, 2013
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File No. 001-02217
(Exact name of Registrant as specified in its Charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
58-0628465
(IRS Employer
Identification No.)
One Coca-Cola Plaza
Atlanta, Georgia
(Address of principal executive offices)
30313
(Zip Code)
Registrant's telephone number, including area code: (404) 676-2121
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No o
Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). Yes No o
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer o
Non-accelerated filer o
(Do not check if a smaller reporting company)
Smaller reporting company o
Indicate by check mark if the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No
Indicate the number of shares outstanding of each of the issuer's classes of common stock as of the latest practicable date.
Class of Common Stock
Outstanding at April 22, 2013
$0.25 Par Value
4,453,755,295 Shares
THE COCA-COLA COMPANY AND SUBSIDIARIES
Table of Contents
Page Number
Forward-Looking Statements
Part I. Financial Information
Item 1.
Financial Statements (Unaudited)
Condensed Consolidated Statements of Income
Three months ended March 29, 2013, and March 30, 2012
Condensed Consolidated Statements of Comprehensive Income
Three months ended March 29, 2013, and March 30, 2012
Condensed Consolidated Balance Sheets
March 29, 2013, and December 31, 2012
Condensed Consolidated Statements of Cash Flows
Three months ended March 29, 2013, and March 30, 2012
Notes to Condensed Consolidated Financial Statements
Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
25
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
43
Item 4.
Controls and Procedures
43
Part II. Other Information
Item 1.
Legal Proceedings
43
Item 1A.
Risk Factors
45
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
45
Item 6.
Exhibits
45
FORWARD-LOOKING STATEMENTS
This report contains information that may constitute "forward-looking statements." Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will" and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future including statements relating to volume growth, share of sales and earnings per share growth, and statements expressing general views about future operating results are forward-looking statements. Management believes that these forward-looking statements are reasonable as and when made. However, caution should be taken not to place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. Our Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our Company's historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in Part II, "Item 1A. Risk Factors" and elsewhere in this report and in our Annual Report on Form 10-K for the year ended December 31, 2012, and those described from time to time in our future reports filed with the Securities and Exchange Commission.
Part I. Financial Information
Item 1. Financial Statements (Unaudited)
THE COCA-COLA COMPANY AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(UNAUDITED)
(In millions except per share data)
Three Months Ended
March 29,
2013
March 30,
2012
NET OPERATING REVENUES
11,035
11,137
Cost of goods sold
4,324
4,348
GROSS PROFIT
6,711
6,789
Selling, general and administrative expenses
4,182
4,181
Other operating charges
121
99
OPERATING INCOME
2,408
2,509
Interest income
116
115
Interest expense
102
88
Equity income (loss) net
87
140
Other income (loss) net
(165
49
INCOME BEFORE INCOME TAXES
2,344
2,725
Income taxes
575
658
CONSOLIDATED NET INCOME
1,769
2,067
Less: Net income attributable to noncontrolling interests
18
13
NET INCOME ATTRIBUTABLE TO SHAREOWNERS OF
THE COCA-COLA COMPANY
1,751
2,054
BASIC NET INCOME PER SHARE1
0.39
0.45
DILUTED NET INCOME PER SHARE1
0.39
0.45
DIVIDENDS PER SHARE
0.28
0.255
AVERAGE SHARES OUTSTANDING
4,455
4,525
Effect of dilutive securities
75
76
AVERAGE SHARES OUTSTANDING ASSUMING DILUTION
4,530
4,601
1 Calculated based on net income attributable to shareowners of The Coca-Cola Company.
Refer to Notes to Condensed Consolidated Financial Statements.
THE COCA-COLA COMPANY AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(UNAUDITED)
(In millions)
Three Months Ended
March 29,
2013
March 30,
2012
CONSOLIDATED NET INCOME
1,769
2,067
Other comprehensive income:
Net foreign currency translation adjustment
70
930
Net gain (loss) on derivatives
87
31
Net unrealized gain (loss) on available-for-sale securities
100
Net change in pension and other benefit liabilities
32
(11
TOTAL COMPREHENSIVE INCOME
1,966
3,117
Less: Comprehensive income (loss) attributable to noncontrolling interests
41
64
TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO SHAREOWNERS OF
THE COCA-COLA COMPANY
1,925
3,053
Refer to Notes to Condensed Consolidated Financial Statements.
THE COCA-COLA COMPANY AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
(In millions except par value)
March 29,
2013
December 31,
2012
ASSETS
CURRENT ASSETS
Cash and cash equivalents
9,162
8,442
Short-term investments
6,176
5,017
TOTAL CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
15,338
13,459
Marketable securities
3,090
3,092
Trade accounts receivable, less allowances of $58 and $53, respectively
5,007
4,759
Inventories
3,607
3,264
Prepaid expenses and other assets
3,294
2,781
Assets held for sale
1,183
2,973
TOTAL CURRENT ASSETS
31,519
30,328
EQUITY METHOD INVESTMENTS
9,850
9,216
OTHER INVESTMENTS, PRINCIPALLY BOTTLING COMPANIES
1,227
1,232
OTHER ASSETS
3,922
3,585
PROPERTY, PLANT AND EQUIPMENT, less accumulated depreciation of
$9,395 and $9,010, respectively
14,543
14,476
TRADEMARKS WITH INDEFINITE LIVES
6,570
6,527
BOTTLERS' FRANCHISE RIGHTS WITH INDEFINITE LIVES
7,414
7,405
GOODWILL
12,291
12,255
OTHER INTANGIBLE ASSETS
1,114
1,150
TOTAL ASSETS
88,450
86,174
LIABILITIES AND EQUITY
CURRENT LIABILITIES
Accounts payable and accrued expenses
9,447
8,680
Loans and notes payable
16,322
16,297
Current maturities of long-term debt
4,505
1,577
Accrued income taxes
382
471
Liabilities held for sale
446
796
TOTAL CURRENT LIABILITIES
31,102
27,821
LONG-TERM DEBT
14,291
14,736
OTHER LIABILITIES
4,949
5,468
DEFERRED INCOME TAXES
5,214
4,981
THE COCA-COLA COMPANY SHAREOWNERS' EQUITY
Common stock, $0.25 par value; Authorized 11,200 shares;
Issued 7,040 and 7,040 shares, respectively
1,760
1,760
Capital surplus
11,664
11,379
Reinvested earnings
58,549
58,045
Accumulated other comprehensive income (loss)
(3,211
(3,385
Treasury stock, at cost 2,592 and 2,571 shares, respectively
(36,282
(35,009
EQUITY ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY
32,480
32,790
EQUITY ATTRIBUTABLE TO NONCONTROLLING INTERESTS
414
378
TOTAL EQUITY
32,894
33,168
TOTAL LIABILITIES AND EQUITY
88,450
86,174
Refer to Notes to Condensed Consolidated Financial Statements.
THE COCA-COLA COMPANY AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(In millions)
Three Months Ended
March 29,
2013
March 30,
2012
OPERATING ACTIVITIES
Consolidated net income
1,769
2,067
Depreciation and amortization
473
447
Stock-based compensation expense
47
77
Deferred income taxes
157
(103
Equity (income) loss net of dividends
(77
(133
Foreign currency adjustments
184
(66
Significant (gains) losses on sales of assets net
(1
(14
Other operating charges
74
63
Other items
36
Net change in operating assets and liabilities
(2,184
(1,846
Net cash provided by operating activities
478
493
INVESTING ACTIVITIES
Purchases of investments
(3,506
(4,664
Proceeds from disposals of investments
2,225
556
Acquisitions of businesses, equity method investments and nonmarketable securities
(28
(120
Proceeds from disposals of businesses, equity method investments and nonmarketable securities
690
11
Purchases of property, plant and equipment
(498
(592
Proceeds from disposals of property, plant and equipment
35
27
Other investing activities
(136
(101
Net cash provided by (used in) investing activities
(1,218
(4,883
FINANCING ACTIVITIES
Issuances of debt
12,585
11,358
Payments of debt
(10,065
(8,835
Issuances of stock
417
436
Purchases of stock for treasury
(1,523
(1,079
Dividends
Other financing activities
21
42
Net cash provided by (used in) financing activities
1,435
1,922
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS
25
329
CASH AND CASH EQUIVALENTS
Net increase (decrease) during the period
720
(2,139
Balance at beginning of period
8,442
12,803
Balance at end of period
9,162
10,664
Refer to Notes to Condensed Consolidated Financial Statements.
THE COCA-COLA COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 1: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. They do not include all information and notes required by generally accepted accounting principles for complete financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the Notes to Consolidated Financial Statements included in the Annual Report on Form 10-K of The Coca-Cola Company for the year ended December 31, 2012.
When used in these notes, the terms "The Coca-Cola Company," "Company," "we," "us" or "our" mean The Coca-Cola Company and all entities included in our condensed consolidated financial statements. In the opinion of management, all adjustments (including normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 29, 2013, are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. Sales of our nonalcoholic ready-to-drink beverages are somewhat seasonal, with the second and third calendar quarters accounting for the highest sales volumes. The volume of sales in the beverage business may be affected by weather conditions.
Each of our interim reporting periods, other than the fourth interim reporting period, ends on the Friday closest to the last day of the corresponding quarterly calendar period. The first quarter of 2013 and 2012 ended on March 29, 2013, and March 30, 2012, respectively. Our fourth interim reporting period and our fiscal year end on December 31 regardless of the day of the week on which December 31 falls.
Effective January 1, 2013, the Company transferred our India and South West Asia business unit from the Eurasia and Africa operating segment to the Pacific operating segment. Accordingly, these and certain other amounts in the prior year's condensed consolidated financial statements and notes have been revised to conform to the current year presentation.
Advertising Costs
The Company's accounting policy related to advertising costs for annual reporting purposes, as disclosed in Note 1 of our 2012 Annual Report on Form 10-K, is to expense production costs of print, radio, television and other advertisements as of the first date the advertisements take place. All other marketing expenditures are expensed in the annual period in which the expenditure is incurred.
For interim reporting purposes, we allocate our estimated full year marketing expenditures that benefit multiple interim periods to each of our interim reporting periods. We use the proportion of each interim period's actual unit case volume to the estimated full year unit case volume as the basis for the allocation. This methodology results in our marketing expenditures being recognized at a standard rate per unit case. At the end of each interim reporting period, we review our estimated full year unit case volume and our estimated full year marketing expenditures in order to evaluate if a change in estimate is necessary. The impact of any changes in these full year estimates is recognized in the interim period in which the change in estimate occurs. Our full year marketing expenditures are not impacted by this interim accounting policy.
NOTE 2: ACQUISITIONS AND DIVESTITURES
Acquisitions
During the three months ended March 29, 2013, our Company's acquisitions of businesses, equity method investments and nonmarketable securities totaled $28 million, none of which were individually significant.
During the three months ended March 30, 2012, our Company's acquisitions of businesses, equity method investments and nonmarketable securities totaled $120 million, which included our acquisition of bottling operations in Vietnam and Cambodia. None of the Company's acquisitions were individually significant.
Divestitures
During the three months ended March 29, 2013, proceeds from disposals of businesses, equity method investments and nonmarketable securities totaled $690 million, which primarily included the sale of a majority ownership interest in our previously consolidated bottling operations in the Philippines ("Philippine bottling operations") to Coca-Cola FEMSA, S.A.B. de C.V. ("Coca-Cola FEMSA"), an equity method investee. The Company now accounts for our ownership interest in the
Philippine bottling operations as an equity method investment, which we remeasured to fair value taking into consideration the sale price of the majority ownership interest. Coca-Cola FEMSA has an option to purchase our remaining ownership interest in the Philippine bottling operations at any time during the seven years following closing at the initial purchase price plus a defined return. Coca-Cola FEMSA also has an option exercisable during the sixth year after closing to sell its ownership interest back to the Company at a price not to exceed the initial purchase price.
During the three months ended March 30, 2012, proceeds from disposals of businesses, equity method investments and nonmarketable securities totaled $11 million, none of which were individually significant.
Assets and Liabilities Held for Sale
On December 13, 2012, the Company and Coca-Cola FEMSA executed a share purchase agreement for the sale of a majority ownership interest in our consolidated Philippine bottling operations. This transaction was completed on January 25, 2013. As of December 31, 2012, our Philippine bottling operations met the criteria to be classified as held for sale, and we were required to record their assets and liabilities at the lower of carrying value or fair value less any costs to sell based on the agreed-upon purchase price. The Company recorded a total loss of $107 million, primarily during the fourth quarter of 2012, on the sale of our Philippine bottling operations. Refer to the table below for a detail of our Philippine bottling assets and liabilities that were classified as held for sale as of December 31, 2012.
On December 17, 2012, the Company entered into an agreement with several parties which will result in the merger of our consolidated bottling operations in Brazil ("Brazilian bottling operations") with an independent bottler in Brazil. Upon completion of the transaction, we will deconsolidate our Brazilian bottling operations in exchange for cash and a minority ownership interest in the newly combined entity. As a result, our Brazilian bottling operations met the criteria to be classified as held for sale. We were not required to record their assets and liabilities at fair value less any costs to sell because their fair value exceeded our carrying value as of March 29, 2013, and December 31, 2012.
The following table presents information related to the major classes of assets and liabilities that were classified as held for sale in our condensed consolidated balance sheets as of March 29, 2013, and December 31, 2012 (in millions):
March 29, 2013
December 31, 2012
Brazilian
Bottling Operations
Brazilian
Bottling Operations
Philippine Bottling Operations
Total Bottling Operations
Held for Sale as of December 31, 2012
Cash, cash equivalents and short-term investments
85
45
133
178
Trade accounts receivable, less allowances
62
88
108
196
Inventories
92
85
187
272
Prepaid expenses and other assets
134
174
223
397
Other assets
182
128
135
Property, plant and equipment net
464
419
841
1,260
Bottlers' franchise rights with indefinite lives
141
130
341
471
Goodwill
23
22
148
170
Other intangible assets
Allowance for reduction of assets held for sale
(107
(107
Total assets
1,183
1,092
1,881
2,973
Accounts payable and accrued expenses
140
157
241
398
Loans and notes payable
15
Current maturities of long-term debt
32
28
28
Accrued income taxes
(4
Long-term debt
152
147
147
Other liabilities
85
75
20
95
Deferred income taxes
21
20
102
122
Total liabilities
446
437
359
796
We determined that our Philippine and Brazilian bottling operations did not meet the criteria to be classified as discontinued operations, primarily due to the continued significant involvement we anticipate having in these operations following each transaction.
NOTE 3: INVESTMENTS
Investments in debt and marketable equity securities, other than investments accounted for under the equity method, are classified as trading, available-for-sale or held-to-maturity. Our marketable equity investments are classified as either trading or available-for-sale with their cost basis determined by the specific identification method. Realized and unrealized gains and losses on trading securities and realized gains and losses on available-for-sale securities are included in net income. Unrealized gains and losses, net of deferred taxes, on available-for-sale securities are included in our condensed consolidated balance sheets as a component of accumulated other comprehensive income ("AOCI"), except for the change in fair value attributable to the currency risk being hedged. Refer to Note 5 for additional information related to the Company's fair value hedges of available-for-sale securities.
Our investments in debt securities are carried at either amortized cost or fair value. Investments in debt securities that the Company has the positive intent and ability to hold to maturity are carried at amortized cost and classified as held-to-maturity. Investments in debt securities that are not classified as held-to-maturity are carried at fair value and classified as either trading or available-for-sale.
Trading Securities
As of March 29, 2013, and December 31, 2012, our trading securities had a fair value of $280 million and $266 million, respectively, and consisted primarily of equity securities. The Company had net unrealized gains on trading securities of $34 million and $19 million as of March 29, 2013, and December 31, 2012, respectively. The Company's trading securities were included in the following line items in our condensed consolidated balance sheets (in millions):
March 29,
2013
December 31,
2012
Marketable securities
195
184
Other assets
85
82
Total trading securities
280
266
Available-for-Sale and Held-to-Maturity Securities
As of March 29, 2013, available-for-sale securities consisted of the following (in millions):
Gross Unrealized
Cost
Gains
Losses
Fair Value
Available-for-sale securities:1
Equity securities
962
459
(12
1,409
Debt securities
3,246
47
(4
3,289
Total available-for-sale securities
4,208
506
(16
4,698
1 Refer to Note 14 for additional information related to the estimated fair value.
As of December 31, 2012, available-for-sale securities consisted of the following (in millions):
Gross Unrealized
Cost
Gains
Losses
Fair Value
Available-for-sale securities:1
Equity securities
957
441
(10
1,388
Debt securities
3,169
46
(10
3,205
Total available-for-sale securities
4,126
487
(20
4,593
1 Refer to Note 14 for additional information related to the estimated fair value.
The sale and/or maturity of available-for-sale securities resulted in the following activity during the three months ended March 29, 2013, and March 30, 2012 (in millions):
Three Months Ended
March 29,
2013
March 30,
2012
Gross gains
Gross losses
(5
(2
Proceeds
1,137
1,231
The Company uses one of its insurance captives to reinsure group annuity insurance contracts that cover the pension obligations of certain of our European pension plans. In accordance with local insurance regulations, our insurance captive is required to meet and maintain minimum solvency capital requirements. The Company elected to invest its solvency capital in a portfolio of available-for-sale securities, which have been classified in the line item other assets in our condensed consolidated balance sheets because the assets are not available to satisfy our current obligations. As of March 29, 2013, and December 31, 2012, the Company's available-for-sale securities included solvency capital funds of $490 million and $451 million, respectively.
The Company's available-for-sale securities were included in the following line items in our condensed consolidated balance sheets (in millions):
March 29,
2013
December 31,
2012
Cash and cash equivalents
100
Marketable securities
2,895
2,908
Other investments, principally bottling companies
1,080
1,087
Other assets
623
589
Total available-for-sale securities
4,698
4,593
The contractual maturities of these available-for-sale securities as of March 29, 2013, were as follows (in millions):
Cost
Fair Value
Within 1 year
1,166
1,171
After 1 year through 5 years
1,502
1,509
After 5 years through 10 years
263
291
After 10 years
315
318
Equity securities
962
1,409
Total available-for-sale securities
4,208
4,698
The Company expects that actual maturities may differ from the contractual maturities above because borrowers have the right to call or prepay certain obligations.
As of March 29, 2013, and December 31, 2012, the Company did not have any held-to-maturity securities.
Cost Method Investments
Cost method investments are initially recorded at cost, and we record dividend income when applicable dividends are declared. Cost method investments are reported as other investments in our condensed consolidated balance sheets, and dividend income from cost method investments is reported in other income (loss) net in our condensed consolidated statements of income. We review all of our cost method investments quarterly to determine if impairment indicators are present; however, we are not required to determine the fair value of these investments unless impairment indicators exist. When impairment indicators exist, we generally use discounted cash flow analyses to determine the fair value. We estimate that the fair values of our cost method investments approximated or exceeded their carrying values as of March 29, 2013, and December 31, 2012. Our cost method investments had a carrying value of $147 million and $145 million as of March 29, 2013, and December 31, 2012, respectively.
NOTE 4: INVENTORIES
Inventories consist primarily of raw materials and packaging (which include ingredients and supplies) and finished goods (which include concentrates and syrups in our concentrate operations and finished beverages in our finished product operations). Inventories are valued at the lower of cost or market. We determine cost on the basis of the average cost or first-in, first-out methods. Inventories consisted of the following (in millions):
March 29,
2013
December 31,
2012
Raw materials and packaging
1,899
1,773
Finished goods
1,375
1,171
Other
333
320
Total inventories
3,607
3,264
NOTE 5: HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS
The Company is directly and indirectly affected by changes in certain market conditions. These changes in market conditions may adversely impact the Company's financial performance and are referred to as "market risks." When deemed appropriate, our Company uses derivatives as a risk management tool to mitigate the potential impact of certain market risks. The primary market risks managed by the Company through the use of derivative instruments are foreign currency exchange rate risk, commodity price risk and interest rate risk.
The Company uses various types of derivative instruments including, but not limited to, forward contracts, commodity futures contracts, option contracts, collars and swaps. Forward contracts and commodity futures contracts are agreements to buy or sell a quantity of a currency or commodity at a predetermined future date, and at a predetermined rate or price. An option contract is an agreement that conveys the purchaser the right, but not the obligation, to buy or sell a quantity of a currency or commodity at a predetermined rate or price during a period or at a time in the future. A collar is a strategy that uses a combination of options to limit the range of possible positive or negative returns on an underlying asset or liability to a specific range, or to protect expected future cash flows. To do this, an investor simultaneously buys a put option and sells (writes) a call option, or alternatively buys a call option and sells (writes) a put option. A swap agreement is a contract between two parties to exchange cash flows based on specified underlying notional amounts, assets and/or indices. We do not enter into derivative financial instruments for trading purposes.
All derivatives are carried at fair value in our condensed consolidated balance sheets in the following line items, as applicable: prepaid expenses and other assets; other assets; accounts payable and accrued expenses; and other liabilities. The carrying values of the derivatives reflect the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. These master netting agreements allow the Company to net settle positive and negative positions (assets and liabilities) arising from different transactions with the same counterparty.
The accounting for gains and losses that result from changes in the fair values of derivative instruments depends on whether the derivatives have been designated and qualify as hedging instruments and the type of hedging relationships. Derivatives can be designated as fair value hedges, cash flow hedges or hedges of net investments in foreign operations. The changes in the fair values of derivatives that have been designated and qualify for fair value hedge accounting are recorded in the same line item in our condensed consolidated statements of income as the changes in the fair values of the hedged items attributable to the risk being hedged. The changes in the fair values of derivatives that have been designated and qualify as cash flow hedges or hedges of net investments in foreign operations are recorded in AOCI and are reclassified into the line item in our condensed consolidated statement of income in which the hedged items are recorded in the same period the hedged items affect earnings. Due to the high degree of effectiveness between the hedging instruments and the underlying exposures being hedged, fluctuations in the value of the derivative instruments are generally offset by changes in the fair values or cash flows of the underlying exposures being hedged. The changes in fair values of derivatives that were not designated and/or did not qualify as hedging instruments are immediately recognized into earnings.
For derivatives that will be accounted for as hedging instruments, the Company formally designates and documents, at inception, the financial instrument as a hedge of a specific underlying exposure, the risk management objective and the strategy for undertaking the hedge transaction. In addition, the Company formally assesses, both at inception and at least quarterly thereafter, whether the financial instruments used in hedging transactions are effective at offsetting changes in either the fair values or cash flows of the related underlying exposures. Any ineffective portion of a financial instrument's change in fair value is immediately recognized into earnings.
The Company determines the fair values of its derivatives based on quoted market prices or pricing models using current market rates. Refer to Note 14. The notional amounts of the derivative financial instruments do not necessarily represent amounts exchanged by the parties and, therefore, are not a direct measure of our exposure to the financial risks described
10
above. The amounts exchanged are calculated by reference to the notional amounts and by other terms of the derivatives, such as interest rates, foreign currency exchange rates or other financial indices. The Company does not view the fair values of its derivatives in isolation, but rather in relation to the fair values or cash flows of the underlying hedged transactions or other exposures. Virtually all of our derivatives are straightforward over-the-counter instruments with liquid markets.
The following table presents the fair values of the Company's derivative instruments that were designated and qualified as part of a hedging relationship (in millions):
Fair Value1,2
Derivatives Designated as
Hedging Instruments
Balance Sheet Location1
March 29,
2013
December 31, 2012
Assets
Foreign currency contracts
Prepaid expenses and other assets
248
149
Foreign currency contracts
Other assets
56
Commodity contracts
Prepaid expenses and other assets
Interest rate contracts
Prepaid expenses and other assets
10
Interest rate contracts
Other assets
313
335
Total assets
628
491
Liabilities
Foreign currency contracts
Accounts payable and accrued expenses
33
55
Foreign currency contracts
Other liabilities
14
Commodity contracts
Accounts payable and accrued expenses
Interest rate contracts
Other liabilities
Total liabilities
54
62
1 All of the Company's derivative instruments are carried at fair value in our condensed consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash collateral. Refer to Note 14 for the net presentation of the Company's derivative instruments.
2 Refer to Note 14 for additional information related to the estimated fair value.
The following table presents the fair values of the Company's derivative instruments that were not designated as hedging instruments (in millions):
Fair Value1,2
Derivatives Not Designated as
Hedging Instruments
Balance Sheet Location1
March 29,
2013
December 31, 2012
Assets
Foreign currency contracts
Prepaid expenses and other assets
36
19
Foreign currency contracts
Other assets
117
42
Commodity contracts
Prepaid expenses and other assets
71
72
Other derivative instruments
Prepaid expenses and other assets
10
Total assets
234
139
Liabilities
Foreign currency contracts
Accounts payable and accrued expenses
20
24
Foreign currency contracts
Other liabilities
20
Commodity contracts
Accounts payable and accrued expenses
50
43
Commodity contracts
Other liabilities
Other derivative instruments
Accounts payable and accrued expenses
Total liabilities
92
71
1 All of the Company's derivative instruments are carried at fair value in our condensed consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash collateral. Refer to Note 14 for the net presentation of the Company's derivative instruments.
2 Refer to Note 14 for additional information related to the estimated fair value.
11
Credit Risk Associated with Derivatives
We have established strict counterparty credit guidelines and enter into transactions only with financial institutions of investment grade or better. We monitor counterparty exposures regularly and review any downgrade in credit rating immediately. If a downgrade in the credit rating of a counterparty were to occur, we have provisions requiring collateral in the form of U.S. government securities for substantially all of our transactions. To mitigate presettlement risk, minimum credit standards become more stringent as the duration of the derivative financial instrument increases. In addition, the Company's master netting agreements reduce credit risk by permitting the Company to net settle for transactions with the same counterparty. To minimize the concentration of credit risk, we enter into derivative transactions with a portfolio of financial institutions. Based on these factors, we consider the risk of counterparty default to be minimal.
Cash Flow Hedging Strategy
The Company uses cash flow hedges to minimize the variability in cash flows of assets or liabilities or forecasted transactions caused by fluctuations in foreign currency exchange rates, commodity prices or interest rates. The changes in the fair values of derivatives designated as cash flow hedges are recorded in AOCI and are reclassified into the line item in our condensed consolidated statements of income in which the hedged items are recorded in the same period the hedged items affect earnings. The changes in fair values of hedges that are determined to be ineffective are immediately reclassified from AOCI into earnings. The Company did not discontinue any cash flow hedging relationships during the three months ended March 29, 2013, or March 30, 2012. The maximum length of time for which the Company hedges its exposure to future cash flows is typically three years.
The Company maintains a foreign currency cash flow hedging program to reduce the risk that our eventual U.S. dollar net cash inflows from sales outside the United States and U.S. dollar net cash outflows from procurement activities will be adversely affected by fluctuations in foreign currency exchange rates. We enter into forward contracts and purchase foreign currency options (principally euros and Japanese yen) and collars to hedge certain portions of forecasted cash flows denominated in foreign currencies. When the U.S. dollar strengthens against the foreign currencies, the decline in the present value of future foreign currency cash flows is partially offset by gains in the fair value of the derivative instruments. Conversely, when the U.S. dollar weakens, the increase in the present value of future foreign currency cash flows is partially offset by losses in the fair value of the derivative instruments. The total notional values of derivatives that were designated and qualified for the Company's foreign currency cash flow hedging program were $5,327 million and $4,715 million as of March 29, 2013, and December 31, 2012, respectively.
The Company has entered into commodity futures contracts and other derivative instruments on various commodities to mitigate the price risk associated with forecasted purchases of materials used in our manufacturing process. These derivative instruments have been designated and qualify as part of the Company's commodity cash flow hedging program. The objective of this hedging program is to reduce the variability of cash flows associated with future purchases of certain commodities. The total notional values of derivatives that were designated and qualified for the Company's commodity cash flow hedging program were $12 million and $17 million as of March 29, 2013, and December 31, 2012, respectively.
Our Company monitors our mix of short-term debt and long-term debt regularly. From time to time, we manage our risk to interest rate fluctuations through the use of derivative financial instruments. The Company has entered into interest rate swap agreements and has designated these instruments as part of the Company's interest rate cash flow hedging program. The objective of this hedging program is to mitigate the risk of adverse changes in benchmark interest rates on the Company's future interest payments. The total notional values of these interest rate swap agreements that were designated and qualified for the Company's interest rate cash flow hedging program were $2,215 million and $1,764 million as of March 29, 2013, and December 31, 2012, respectively.
12
The following table presents the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on AOCI and earnings during the three months ended March 29, 2013 (in millions):